NEW STRATEGIES AND APPROACHES TO IMPROVE ALCOHOL CLINICAL TRIALS AND INFORM REGULATORY GUIDANCE

被引：0
|
作者：
Litten, R. Z. [1 ]
机构：
[1] NIAAA, Bethesda, MD 20892 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2010年 / 34卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：88A / 88A
页数：1
相关论文
共 50 条
  • [21] The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice
    Malcolm, Robert
    Olive, M. Foster
    Lechner, William
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (04) : 459 - 472
  • [22] Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies
    Edwards, Scott
    Vendruscolo, Leandro F.
    Gilpin, Nicholas W.
    Wojnar, Marcin
    Witkiewitz, Katie
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 (02): : 368 - 383
  • [23] COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union
    de Jong, Amos Jochanan
    Santa-Ana-Tellez, Yared
    van Thiel, Ghislaine Jose Madeleine Wilhelmien
    Zuidgeest, Mira Gerta Petra
    Siiskonen, Satu Johanna
    Mistry, Dinesh
    de Boer, Anthonius
    Gardarsdottir, Helga
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (06) : 1517 - 1527
  • [24] The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance
    Hoffmann, Jean-Marc
    Bauer, Annina
    Grossmann, Regina
    BMJ GLOBAL HEALTH, 2023, 8 (09):
  • [25] New guidance to improve sample size calculations for trials: eliciting the target difference
    Bell, Melanie L.
    TRIALS, 2018, 19
  • [26] New guidance to improve sample size calculations for trials: eliciting the target difference
    Melanie L. Bell
    Trials, 19
  • [27] Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials
    Wiens, Brian L.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (01) : 52 - 62
  • [28] Strategies to improve minority patient accrual to cancer clinical trials.
    Wujcik, DM
    Ikpeazu, C
    Chinratanalab, W
    Wolff, SN
    Kinnard, C
    McCullough, N
    Mason, HRC
    Stain, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 523S - 523S
  • [29] New approaches for monitoring CTL activity in clinical trials
    Malyguine, Anatoli
    Strobl, Susan
    Zaritskaya, Liubov
    Baseler, Michael
    Shafer-Weaver, Kimberly
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 273 - 284
  • [30] Theory-based strategies to improve recruitment and retention in clinical trials
    Weber, BA
    Mills, TL
    Chumbler, N
    PSYCHO-ONCOLOGY, 2005, 14 (01) : S73 - S73
12345